August 29, 2018

Media

Media & events

news

Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products

September 7, 2017
Companies will collaborate to create products dosed once-weekly for the treatment of Alzheimer’s disease. Lyndra, Inc. (Lyndra) announced today a...
Read More

publications

awardS

Lyndra Named as Scrip Award Finalist in Two Categories

Happy to announce our ultra-long acting oral dosage form has been named a finalist for the Scrip MSD Innovation Award, and our co-founder Amy Schulman has been named a finalist in the Executive of the Year category!

#ScripAwards

Amy Schulman, Lyndra Co-founder and CEO, honored on 2019 PharmaVOICE 100

“Amy’s fearless approach to create durable value and change the trajectory of compliance for some of most difficult to treat diseases —  Alzheimer’s disease, HIV, opioid use disorder, and schizophrenia — are just a couple of the reasons she has been identified as one of the 100 most inspiring people in the life-sciences industry,” says Taren Grom, editor, PharmaVOICE

#PharmaVOICE

2019 Xconomy Awards Finalist in Startup Category

We are honored to be named a finalist for the Awards in the category for our work making daily pills a thing of the past.

#XconomyAwards

events

Lyndra Presents @ BIO International

Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4

2019 BIO International